GNLX
Genelux Corp

451
Loading...
Loading...
News
all
press releases
Unveiling 4 Analyst Insights On Genelux
read more...
Benzinga·1y ago
News Placeholder
More News
News Placeholder
Why Genelux Corporation (GNLX) Shares Are Down 40%
Genelux shares are trading lower by 40.7% during Friday's session. The company announced the pricing of an underwritten offering of 6.875 million shares. read more...
Benzinga·1y ago
News Placeholder
Brokers Set Expectations for Genelux Co.'s FY2028 Earnings (NASDAQ:GNLX)
Genelux Co. (NASDAQ:GNLX - Free Report) - Research analysts at HC Wainwright issued their FY2028 EPS estimates for shares of Genelux in a research report issued to clients and investors on...
Zolmax·1y ago
News Placeholder
Genelux (NASDAQ:GNLX) Price Target Lowered to $32.00 at HC Wainwright
Genelux (NASDAQ:GNLX - Free Report) had its price objective reduced by HC Wainwright from $35.00 to $32.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a...
Zolmax·1y ago
News Placeholder
GNLX Stock Earnings: Genelux Misses EPS for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips GNLX stock results show that Genelux missed analyst estimates for earnings per share the fourth quarter of 2023. The post GNLX Stock...
InvestorPlace·1y ago
News Placeholder
Genelux Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Continued active enrollment of Olvi-Vec in our pivotal Phase 3 OnPrime/GOG-3076 trial in platinum resistant/refractory ovarian cancer with topline results anticipated in 2H 2025 Initiation of...
Globe Newswire·1y ago
News Placeholder
Genelux reports Q4 EPS (25c), consensus (19c)
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
LifeSteps Financial Inc. Purchases 2,191 Shares of Genelux Co. (NASDAQ:GNLX)
LifeSteps Financial Inc. boosted its position in Genelux Co. (NASDAQ:GNLX - Free Report) by 6.7% during the fourth quarter, according to the company in its most recent filing with the Securities...
Ticker Report·1y ago
News Placeholder
12 titres de soins de sant en mouvement lors de la session apr s-cl ture le 08/03/2024
Gagnants L'action Genelux (NASDAQ:GNLX) a mont vendredi de 10,06% 7 dollars lors de la session after-market. L'action Telesis Bio (NASDAQ:TBIO) a mont de 9,28% 0,60 dollars. Le titre Estrella...
Benzinga·1y ago
News Placeholder
12 titoli sanitari in movimento, after-market del 08/03/2024
Titoli in rialzo Le azioni di Genelux (NASDAQ:GNLX) hanno fatto segnare +10,06% a 7 dollari durante la sessione after-market di venerd . Il titolo Telesis Bio (NASDAQ:TBIO) ha avuto un aumento del...
Benzinga·1y ago

Latest GNLX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.